FMC Prattville is a medicare approved dialysis facility center in Prattville, Alabama and it has 18 dialysis stations. It is located in Autauga county at 692 Covered Bridge Parkway, Prattville, AL, 36066. You can reach out to the office of FMC Prattville at (334) 358-7414. This dialysis clinic is managed and/or owned by Fresenius Medical Care. FMC Prattville has the following ownership type - Profit. It was first certified by medicare in September, 2009. The medicare id for this facility is 012633 and it accepts patients under medicare ESRD program.
| Name | FMC Prattville |
|---|---|
| Location | 692 Covered Bridge Parkway, Prattville, Alabama |
| No. of Dialysis Stations | 18 |
| Medicare ID | 012633 |
| Managed By | Fresenius Medical Care |
| Ownership Type | Profit |
| Late Shifts | No |
| 692 Covered Bridge Parkway, Prattville, Alabama, 36066 | |
| (334) 358-7414 | |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
| NPI Number | 1982842548 |
| Organization Name | Fresenius Medical Care Prattville |
| Doing Business As | Bio-medical Applications Of Alabama Inc |
| Address | 692 Covered Bridge Parkway Prattville, Alabama, 36066 |
| Phone Number | (334) 358-7414 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that nephrologists always communicated and cared for them. | 72% | 67% |
| Patients who reported that nephrologists usually communicated and cared for them. | 5% | 15% |
| Patients who reported that nephrologists sometimes or never communicated and cared for them. | 23% | 18% |
| Patients who gave their nephrologists a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 64% | 60% |
| Patients who gave their nephrologists a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 20% | 26% |
| Patients who gave their nephrologists a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 16% | 14% |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that dialysis center staff always communicated well, kept patients comfortable and pain-free as possible. | 57% | 62% |
| Patients who reported that dialysis center staff usually communicated, kept patients comfortable and pain-free as possible. | 14% | 20% |
| Patients who reported that dialysis center staff sometimes or never communicated, kept patients comfortable and pain-free. | 29% | 18% |
| Patients who gave their dialysis facility staff a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 54% | 62% |
| Patients who gave their dialysis facility staff a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 33% | 26% |
| Patients who gave their dialysis facility staff a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 13% | 12% |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Patients who reported that 'YES', their nephrologists and dialysis center staff provided them the information they needed to take care of them. | 68% | 80% |
| Patients who reported that 'NO', their nephrologists and dialysis center staff does not provided them the information they needed to take care of them. | 32% | 20% |
| Patients who gave their dialysis center a rating of 9 or 10 on a scale of 0 (worst possible) to 10 (best possible). | 60% | 68% |
| Patients who gave their dialysis center a rating of 7 or 8 on a scale of 0 (worst possible) to 10 (best possible). | 28% | 20% |
| Patients who gave their dialysis center a rating of 6 or less than 6 on a scale of 0 (worst possible) to 10 (best possible). | 12% | 12% |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
| Dialysis patients with Hemoglobin data | 32 |
| Medicare patients who had average hemoglobin (hgb) less than 10 g/dL | 13 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.
| Adult patients getting regular hemodialysis at the center | 71 |
| Adult patient months included in Kt/V greater than or equal to 1.2 | 646 |
| Percentage of adult patients getting regular hemodialysis at the center | 98 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at FMC Prattville with elevated calcium levels.
| Patients with hypercalcemia | 71 |
| Hypercalcemia patient months | 649 |
| Patients with Serumphosphor | 77 |
| Patients with Serumphosphor less than 3.5 mg/dL | 9 |
| Patients with Serumphosphor from 3.5 to 4.5 mg/dL | 30 |
| Patients with Serumphosphor from 4.6 to 5.5 mg/dL | 38 |
| Patients with Serumphosphor from 5.6 to 7 mg/dL | 16 |
| Patients with Serumphosphor greater than 7 mg/dL | 6 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.
| Patients included in arterial venous fistula and catheter summaries | 66 |
| Patient months included in arterial venous fistula and catheter summaries | 459 |
| Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment | 58 |
| Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer | 11 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
The rate of hospitalization show you whether patients who were being treated regularly at a certain dialysis center were admitted to the hospital more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other centers.
| Standard Hospitalization Summary Ratio(SHR) Year | January, 2016 - December, 2016 |
| Patients in facility's Hospitalization Summary | 55 |
| Hospitalization Rate in facility | 129.7 (As Expected) |
| Hospitalization Rate: Upper Confidence Limit | 274.9 |
| Hospitalization Rate: Lower Confidence Limit | 64.6 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
The rate of readmission show you whether patients who were being treated regularly at FMC Prattville were readmitted more often (worse than expected), less often (better than expected), or about the same (as expected), compared to similar patients treated at other dialysis centers.
| Standard Readmission Summary Ratio(SRR) Year | January, 2016 - December, 2016 |
| Readmission Rate in facility | 16.9 (As Expected) |
| Readmission Rate: Upper Confidence Limit | 31.2 |
| Readmission Rate: Lower Confidence Limit | 7.3 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
Hemodialysis treatment requires direct access to the bloodstream, which can be an opportunity for germs to enter the body and cause infection. This information shows how often patients at FMC Prattville get infections in their blood each year compared to the number of infections expected for the center based on the national average.
| Standard Infection Summary Ratio(SIR) Year | January, 2016 - December, 2016 |
| Infection Rate in facility | .25 (As Expected) |
| SIR: Upper Confidence Limit | 1.21 |
| SIR: Lower Confidence Limit | .01 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
Patients with anemia require blood transfusions if their anemia is not managed well by their dialysis center. This information shows whether FMC Prattville's rate of transfusions is better than expected, as expected, or worse than expected, compared to other centers that treat similar patients.
| Standard Transfusion Summary Ratio (STrR) Year | January, 2016 - December, 2016 |
| Patients in facility's Transfusion Summary | 46 |
| Transfusion Rate in facility | 18.2 (As Expected) |
| Transfusion Rate: Upper Confidence Limit | 106.5 |
| Transfusion Rate: Lower Confidence Limit | 3.9 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
The rate of mortality show you whether patients who were being treated regularly at FMC Prattville lived longer than expected (better than expected), don’t live as long as expected (worse than expected), or lived as long as expected (as expected), compared to similar patients treated at other facilities.
| Standard Survival Summary Ratio(SIR) Year | January, 2013 - December, 2016 |
| Patients in facility's Survival Summary | 235 |
| Mortality Rate in facility | 19.6 (As Expected) |
| Mortality Rate: Upper Confidence Limit | 28 |
| Mortality Rate: Lower Confidence Limit | 13.2 |
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago
News Archive
Later this month, "[f]our former heads of state and other high-level African leaders who are the champions for a HIV/AIDS-free generation project" will travel to Zambia at the request of Zambian President Rupiah Banda for a meeting to discuss ways to strengthen the HIV/AIDS response in Africa, Times of Zambia/allAfrica.com reports.
Pfizer has said that a federal court in the Middle District of North Carolina has upheld the company's U.S. patent covering amlodipine besylate, the active ingredient in Norvasc, the world's most-prescribed branded medicine for treating hypertension.
UC San Diego Health System has been recognized by the Integrated Healthcare Association (IHA) as a "Top Overall Physician Performing Organization" in California.
Although national guidelines advise doctors to discuss the benefits and harms of lung cancer screening with high-risk patients because of a high rate of false positives and other factors, those conversations aren't happening the way they should be, according to a study by researchers from the University of North Carolina Lineberger Comprehensive Cancer Center.
Galectin Therapeutics Inc., the leader in developing carbohydrate-based therapeutic compounds to inhibit galectin receptors, today announced the formation of its Liver Fibrosis Clinical Trials Advisory Board comprised of key opinion leaders from Emory Hospital and School of Medicine, Massachusetts General Hospital and Harvard School of Medicine, University of Michigan Hospital and School of Medicine, Mount Sinai Hospital and School of Medicine, and University of Wisconsin Hospital and School of Medicine.
› Verified 9 days ago